Technical Momentum and Indicator Analysis
Recent technical assessments reveal a clear deterioration in Solara Active’s price momentum. The Moving Average Convergence Divergence (MACD) indicator, a widely followed momentum oscillator, remains bearish on the weekly chart and mildly bearish on the monthly timeframe. This suggests that the stock’s short-term momentum is weakening, with the potential for further downside pressure in the near term.
The Relative Strength Index (RSI), however, does not currently provide a definitive signal on either the weekly or monthly charts, indicating a lack of strong momentum either way. This neutral RSI reading suggests that while the stock is not yet oversold, it is also not showing signs of a robust recovery.
Bollinger Bands, which measure volatility and price levels relative to recent averages, are bearish on both weekly and monthly charts. The stock price is trading near the lower band, signalling increased selling pressure and a potential continuation of the downward trend.
Daily moving averages further reinforce the bearish outlook, with the stock price consistently trading below key averages such as the 50-day and 200-day moving averages. This alignment typically indicates a sustained downtrend and discourages short-term buying interest.
Additional Technical Signals and Trend Assessments
The Know Sure Thing (KST) indicator, which aggregates multiple rate-of-change measures, is bearish on the weekly chart and mildly bearish on the monthly chart. This confirms the weakening momentum across multiple timeframes.
Interestingly, the Dow Theory analysis shows a mildly bullish signal on the weekly chart but no clear trend on the monthly chart. This divergence suggests some short-term optimism among traders, but the longer-term trend remains uncertain.
On-Balance Volume (OBV), a volume-based indicator that tracks buying and selling pressure, is mildly bearish on the weekly chart and neutral on the monthly chart. This indicates that volume trends are not strongly supporting a reversal, adding to the cautious outlook.
Price and Return Performance in Context
Solara Active’s current price of ₹561.45 is significantly below its 52-week high of ₹734.20, highlighting the stock’s vulnerability over the past year. The 52-week low stands at ₹441.10, indicating a wide trading range and elevated volatility.
Comparing returns with the broader Sensex index reveals underperformance across multiple periods. Over the past week, Solara Active declined by 0.31%, while the Sensex fell 1.18%, showing relative resilience in the very short term. However, over the past month, the stock gained 1.89% compared to a 1.08% decline in the Sensex, suggesting some recent strength.
Year-to-date, the stock is down 0.34%, whereas the Sensex has declined 1.22%. Over the last year, Solara Active has suffered a steep 19.33% loss, contrasting with the Sensex’s 7.72% gain. Longer-term returns also paint a challenging picture, with a 5-year loss of 53.45% against a 72.56% gain in the Sensex, and a 3-year gain of 35.54% lagging behind the Sensex’s 40.53%.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
Mojo Score and Rating Implications
MarketsMOJO’s proprietary scoring system has downgraded Solara Active Pharma Sciences Ltd from a Sell to a Strong Sell rating as of 23 December 2025. The current Mojo Score stands at 14.0, reflecting a significant deterioration in the company’s technical and fundamental outlook. The Market Cap Grade remains low at 3, indicating limited market capitalisation strength relative to peers.
This downgrade aligns with the bearish technical signals and the stock’s underperformance relative to the broader market. Investors should exercise caution, as the combination of weak momentum indicators and a negative rating suggests limited near-term upside potential.
Sector and Industry Context
Operating within the Pharmaceuticals & Biotechnology sector, Solara Active faces sector-specific challenges including regulatory pressures, pricing constraints, and competitive dynamics. While the sector has shown pockets of resilience, the company’s technical indicators lag behind industry averages, signalling potential headwinds.
Investors should consider the broader sector trends alongside Solara Active’s individual technical profile when making allocation decisions.
Considering Solara Active Pharma Sciences Ltd? Wait! SwitchER has found potentially better options in Pharmaceuticals & Biotechnology and beyond. Compare this small-cap with top-rated alternatives now!
- - Better options discovered
- - Pharmaceuticals & Biotechnology + beyond scope
- - Top-rated alternatives ready
Outlook and Investor Considerations
Given the current technical landscape, Solara Active Pharma Sciences Ltd appears to be in a bearish phase with limited signs of immediate recovery. The convergence of bearish MACD, moving averages, and Bollinger Bands on multiple timeframes suggests that the stock may continue to face downward pressure.
Investors should weigh these technical signals against fundamental factors and sector dynamics. The absence of strong RSI or OBV signals indicates that a clear reversal is not imminent, and caution is warranted.
Long-term investors may want to monitor the stock’s ability to hold above its 52-week low of ₹441.10, while short-term traders should be mindful of the prevailing bearish momentum and potential volatility.
In summary, the downgrade to a Strong Sell rating by MarketsMOJO, combined with deteriorating technical indicators, underscores a cautious stance on Solara Active Pharma Sciences Ltd at present.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
